stage III cutaneous T-cell non-Hodgkin lymphoma
Showing 9976 - 10000 of >10,000
Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)
Active, not recruiting
- Post-transplant Lymphoproliferative Disorder
- Rituximab
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023
Oral Cancer, Esophageal Cancer, Larynx Cancer Trial (Narrative pictorial warning labels for alcoholic beverages, Non-narrative
Not yet recruiting
- Oral Cancer
- +3 more
- Narrative pictorial warning labels for alcoholic beverages
- Non-narrative pictorial warning labels for alcoholic beverages
- (no location specified)
Nov 8, 2023
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023
Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,
Withdrawn
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- +8 more
- Ibrutinib
- Quality-of-Life Assessment
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 2, 2022
Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (TCRaß+/CD19+ depleted allogeneic hematopoietic stem cell
Recruiting
- Allogeneic Hematopoietic Cell Transplantation
- TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 21, 2021
NSCLC Trial in Tai'an (Ametinib combined with bevacizumab)
Recruiting
- Non-small Cell Lung Cancer
- Ametinib combined with bevacizumab
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Feb 22, 2023
Patient Satisfaction With Facial Appearance: Development and
Completed
- Head and Neck Cancer
- Psychosocial Effects of Cancer and Its Treatment
- questionnaire administration
- +3 more
-
New York, New York
- +3 more
Dec 20, 2021
Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2023
Non Small Cell Lung Cancer, Breast Cancer Trial in Spokane Valley (YL202)
Recruiting
- Non Small Cell Lung Cancer
- Breast Cancer
-
Spokane Valley, WashingtonSummit Cancer Center
Dec 14, 2022
Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)
Not yet recruiting
- Hematopoietic Stem Cell Transplant
- Cardio-oncology program
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 6, 2023
Primary Hyperparathyroidism and Gut Microbiota
Recruiting
- Hyperparathyroidism, Primary
- there will be no intervention, this is an observational study
-
Lausanne, SwitzerlandPatrizia D'amelio
Feb 28, 2022
Advanced Pancreatic Carcinoma Trial in Shenzhen (CD276 CAR-T cells)
Recruiting
- Advanced Pancreatic Carcinoma
- CD276 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Dec 2, 2021
Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- (no location specified)
Dec 20, 2022
Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T
Recruiting
- Anaplastic Thyroid Cancer
- Relapsed/Refractory Poorly Differentiated Thyroid Cancer
- AIC100 CAR T Cells
-
New York, New YorkWeill Cornell Medical College
Feb 14, 2022
Hepatocellular Carcinoma Trial in Guangzhou (TACE(Transcatheter arterial chemoembolization), Lenvatinib)
Recruiting
- Hepatocellular Carcinoma
- TACE(Transcatheter arterial chemoembolization)
- Lenvatinib
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Relapsed Refractory Multiple Myeloma Trial in United States (NEXI-002 T Cells)
Recruiting
- Relapsed Refractory Multiple Myeloma
- NEXI-002 T Cells
-
Duarte, California
- +5 more
Dec 1, 2020
Solid Tumours in Advanced Stages Trial in Italy
Recruiting
- Solid Tumours in Advanced Stages
-
Ancona, Italy
- +41 more
Jun 15, 2023
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in
Not yet recruiting
- Healthy
- Multiple Sclerosis
- Blood sample
-
Orléans, FranceCHR Orléans
Feb 16, 2023
Lung Tumors, Esophageal Tumors, Stomach Tumors Trial in Ottawa (Integrative Care)
Completed
- Lung Neoplasms
- +2 more
- Integrative Care
-
Ottawa, Ontario, Canada
- +1 more
Aug 8, 2022
Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)
Recruiting
- Stage III Colon Cancer
- Signatera test
- +5 more
-
Pittsburgh, PennsylvaniaNRG Oncology - Pittsburgh Center
Mar 30, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)
Recruiting
- Non Small Cell Lung Cancer
- Telisotuzumab Vedotin
- Docetaxel
-
Los Angeles, California
- +212 more
Jan 26, 2023
Postoperative Delirium in Elderly Patients Undergoing
Recruiting
- Postoperative Delirium
-
New Delhi, Delhi, India
- +1 more
Mar 22, 2022